| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $52.1M | -11.9% |
| SG&A Expense | $27.0M | -9.9% |
| Operating Income | -$79.1M | +11.2% |
| Income Tax | $0 | — |
| Net Income | -$76.4M | +13.4% |
| EPS (Basic) | -$2.78 | +13.7% |
| EPS (Diluted) | -$2.78 | +13.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.7M | -62.9% |
| Current Assets | $48.1M | -61.3% |
| Total Assets | $60.9M | -56.2% |
| Current Liabilities | $16.0M | -24.4% |
| Total Liabilities | $24.1M | -28.1% |
| Stockholders' Equity | $36.8M | -65.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$68.6M | +9.4% |
| Capital Expenditures | $486K | -74.0% |
| Investing Cash Flow | -$486K | +74.0% |
| Financing Cash Flow | -$6.5M | -9392.8% |
| Free Cash Flow | -$69.1M | +10.9% |